Literature DB >> 6823355

Voiding difficulties in the female: prevalence, clinical and urodynamic review.

S L Stanton, C Ozsoy, P Hilton.   

Abstract

The urodynamic questionnaires of 600 consecutive female patients attending a urodynamic clinic with a variety of urologic symptoms were reviewed. Investigations consisted of independent uroflowmetry and either twin-channel subtracted cystometry or videocystourethrography with synchronous bladder pressure and urine flow recordings. Urodynamic evidence of voiding difficulty was defined as a repeated peak flow rate of less than 15 ml/sec or more than 200 ml of residual urine. One hundred ninety-five patients complained of voiding difficulties; this was substantiated in only 87. An additional 12 patients had no symptoms suggestive of impaired voiding, but had urodynamic evidence of voiding difficulty. Symptoms of voiding difficulty were found to be unreliable. Neurologic disease was a significant etiologic finding. Uroflowmetry was advised for patients who were to undergo suprapubic surgery for incontinence or radical pelvic surgery.

Entities:  

Mesh:

Year:  1983        PMID: 6823355

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

1.  Symptoms of voiding dysfunction: what do they really mean?

Authors:  H P Dietz; B T Haylen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-08-03

2.  The incidence of urinary tract infection of different routes of catheterization following gynecologic surgery: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Meixuan Li; Liang Yao; Caiwen Han; Huijuan Li; Yangqin Xun; Peijing Yan; Meng Wang; Wenbo He; Cuncun Lu; Kehu Yang
Journal:  Int Urogynecol J       Date:  2018-10-29       Impact factor: 2.894

Review 3.  Voiding dysfunction in the female patient: is the "syndrome" paradigm valid?

Authors:  Hari Siva G R Tunuguntla; Renuka Tunuguntla; Joseph Barone; Prashanth Kanagarajah; Angelo E Gousse
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

4.  Efficacy and safety of combined therapy with tamsulosin and tolterodine in female patients with a maximal flow rate less than 12 ml/s.

Authors:  Sun-Ouck Kim; Eu Chang Hwang; Kyung Jin Oh; Dongdeuk Kwon; Kwangsung Park; Soo Bang Ryu
Journal:  Int Urogynecol J       Date:  2011-05-27       Impact factor: 2.894

5.  Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia?

Authors:  Victor W Nitti
Journal:  Rev Urol       Date:  2005

6.  The effect of urethral dilatation on pressure flow studies in women with voiding dysfunction and overactive bladder.

Authors:  Maya Basu; Jonathan Duckett
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-15

7.  Effect of alfuzosin on female primary bladder neck obstruction.

Authors:  A Athanasopoulos; K Gyftopoulos; K Giannitsas; P Perimenis
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-11-04

8.  Risk factors of voiding dysfunction and patient satisfaction after tension-free vaginal tape procedure.

Authors:  Sungchan Park; Bumsik Hong; Kyu-Sung Lee; Myung-Soo Choo
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

9.  Obstructive voiding symptoms are not predictive of elevated postvoid residual urine volumes.

Authors:  Lior Lowenstein; Charles Anderson; Kimberly Kenton; Yashika Dooley; Linda Brubaker
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

Review 10.  Tamsulosin for voiding dysfunction in women.

Authors:  Laura E Meyer; Jamie N Brown
Journal:  Int Urol Nephrol       Date:  2012-09-16       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.